跳至主要内容
临床试验/CTRI/2020/07/026588
CTRI/2020/07/026588尚未招募未知

To assess the role of statins as an adjunctive anti-VEGF therapy for clinically significant macular edema (CSME) in type 2 diabetes mellitus.

ADVANCED EYE CENTER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Following will be the inclusion criteria:
  • Patients with Non proliferative diabetic retinopathy(NPDR) and clinically significant macular edema(CSME), who are treatment naïve (not having received any form of treatment for CSME in the form of anti-VEGF, intravitreal steroids or laser therapy).
  • Patients who are not treatment naive, but have received any form of above mentioned therapy for CSME atleast three months prior to enrolment.
  • Patients who have not received any previous statin therapy (or are off statin therapy for at least six months).
  • 4.Patients willing to give consent and come for regular follow ups.

排除标准

  • Patients with proliferative diabetic retinopathy, pregnant or lactating women, patients with hepatic or renal insufficiency, any evidence of systemic inflammation or malignancy, patients with increased creatine phosphokinase or deranged liver function tests (LFTs0 or kidney function tests (KFTs) will be excluded from the study.

研究者

发起方
ADVANCED EYE CENTER

相似试验